EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model

Journal of Surgical Research

Volumn 173, Issue 1, 2012, Pages 1-9

  Chernoguz, Artur ^a   Crawford, Kelly ^a   Donovan, Eileen ^a   Vandersall, Abbey ^a   Berglund, Caroline ^a   Cripe, Timothy P ^a   Frischer, Jason S ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

angiogenesis; EGFR; epidermal growth factor; Ewing's sarcoma; gefitinib; microvessel density

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; VASCULOTROPIN;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

ANGIOGRAPHY; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SARCOMA, EWING; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857044050     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.041     Document Type: Article

References (30)

1. N.J. Balamuth, and R.B. Womer Ewing's sarcoma Lancet Oncol 11 2010 184
2. J. Folkman Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction Cancer Metastasis Rev 9 1990 171
3. S. Dalal, A.M. Berry, and C.J. Cullinane Vascular endothelial growth factor: A therapeutic target for tumors of the Ewing's sarcoma family Clin Cancer Res 11 2005 2364
4. M. Kreuter, R. Bieker, and S.S. Bielack Prognostic relevance of increased angiogenesis in osteosarcoma Clin Cancer Res 10 2004 8531
5. J.S. Frischer, J. Huang, and A. Serur Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature Int J Oncol 25 2004 549
6. J. Huang, J.S. Frischer, and A. Serur Regression of established tumors and metastases by potent vascular endothelial growth factor blockade Proc Natl Acad Sci USA 100 2003 7785
7. J. Huang, J.S. Frischer, and T. New TNP-470 promotes initial vascular sprouting in xenograft tumors Mol Cancer Ther 3 2004 335
8. K.N. Richards, P.A. Zweidler-McKay, and N. Van Roy Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo Cancer 116 2010 3233
9. D.N. Amin, K. Hida, D.R. Bielenberg, and M. Klagsbrun Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors Cancer Res 66 2006 2173
10. R. Ho, J.E. Minturn, and T. Hishiki Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor Cancer Res 65 2005 9868
11. J.R. Woodburn The epidermal growth factor receptor and its inhibition in cancer therapy Pharmacol Ther 82 1999 241
12. A.L. Harris, S. Nicholson, J.R. Sainsbury, J. Farndon, and C. Wright Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu J Steroid Biochem 34 1989 123
13. A. Hirata, S. Ogawa, and T. Kometani ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase Cancer Res 62 2002 2554
14. R. Kumar, and R. Yarmand-Bagheri The role of HER2 in angiogenesis Semin Oncol 28 5 Suppl 16 2001 27
15. P. Beaudry, M. Nilsson, and M. Rioth Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium Mol Cancer Ther 7 2008 418
16. W. Wu, M.S. O'Reilly, and R.R. Langley Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice Mol Cancer Ther 6 2007 2652
17. D. Amin, D.R. Bielenberg, E. Lifshits, J.V. Heymach, and M. Klagsbrun Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells Microvasc Res 76 2008 15
18. M.K. Andersson, and P. Aman Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib Cancer Cell Int 8 2008 1
19. A.L. Myers, R.F. Williams, C.Y. Ng, J.E. Hartwich, and A.M. Davidoff Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation J Pediatr Surg 45 2010 1080
20. J. Huang, J.O. Bae, and J.P. Tsai Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade Int J Oncol 34 2009 79
21. J.A. Engelman, P.A. Janne, and C. Mermel ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines Proc Natl Acad Sci U S A 102 2005 3788
22. P. Jedlicka Ewing sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions Int J Clin Exp Pathol 3 2010 338
23. S. Naraghi, S. Khoshyomn, J.A. DeMattia, and D.W. Vane Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro J Pediatr Surg 35 2000 884
24. M.A. Smith, C.L. Morton, D. Phelps, K. Girtman, G. Neale, and P.J. Houghton SK-NEP-1 and Rh1 are Ewing family tumor lines Pediatr Blood Cancer 50 2008 703
25. L. Mattii, F. Bianchi, I. Da Prato, A. Dolfi, and N. Bernardini Renal cell cultures for the study of growth factor interactions underlying kidney organogenesis In Vitro Cell Dev Biol Anim 37 2001 251
26. R.N. Jorissen, F. Walker, N. Pouliot, T.P. Garrett, C.W. Ward, and A.W. Burgess Epidermal growth factor receptor: Mechanisms of activation and signalling Exp Cell Res 284 2003 31
27. J.Y. Fang, and B.C. Richardson The MAPK signalling pathways and colorectal cancer Lancet Oncol 6 2005 322
28. I. Vivanco, and I.K. Mellinghoff Epidermal growth factor receptor inhibitors in oncology Curr Opin Oncol 22 2010 573
29. A. Yokoi, K.W. McCrudden, and J. Huang Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor J Pediatr Surg 38 2003 1569
30. B. Fuchs, C.Y. Inwards, and R. Janknecht Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma Clin Cancer Res 10 2004 1344